Mid-term beta-blocker treatment after low risk acute coronary syndrome

Eur J Prev Cardiol. 2019 Jan;26(1):105-108. doi: 10.1177/2047487318784671. Epub 2018 Jun 22.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Acute Coronary Syndrome / diagnosis
  • Acute Coronary Syndrome / mortality
  • Acute Coronary Syndrome / physiopathology
  • Acute Coronary Syndrome / therapy*
  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Revascularization* / adverse effects
  • Myocardial Revascularization* / mortality
  • Prospective Studies
  • Registries
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists